Free Trial

Teladoc Health (TDOC) Competitors

+0.06 (+0.62%)
(As of 06/21/2024 ET)


Should you be buying Teladoc Health stock or one of its competitors? The main competitors of Teladoc Health include Hims & Hers Health (HIMS), Auna (AUNA), LifeMD (LFMD), AirSculpt Technologies (AIRS), SHL Telemedicine (SHLT), Pono Capital Two (PTWO), Oncology Institute (TOI), Cano Health (CANOQ), Concord Medical Services (CCM), and Penumbra (PEN).

Teladoc Health vs.

Hims & Hers Health (NYSE:HIMS) and Teladoc Health (NYSE:TDOC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, dividends, community ranking, risk, profitability, valuation and earnings.

Hims & Hers Health has higher earnings, but lower revenue than Teladoc Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$872M5.46-$23.55M-$0.01-2,215.00
Teladoc Health$2.62B0.63-$220.37M-$1.41-6.89

In the previous week, Hims & Hers Health had 3 more articles in the media than Teladoc Health. MarketBeat recorded 24 mentions for Hims & Hers Health and 21 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.74 beat Hims & Hers Health's score of 0.02 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
6 Very Positive mention(s)
7 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Teladoc Health
3 Very Positive mention(s)
0 Positive mention(s)
13 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)

Hims & Hers Health has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.

Hims & Hers Health has a net margin of -0.24% compared to Hims & Hers Health's net margin of -8.90%. Teladoc Health's return on equity of -0.70% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.24% -0.70% -0.55%
Teladoc Health -8.90%-10.13%-5.37%

Teladoc Health received 640 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 63.35% of users gave Teladoc Health an outperform vote while only 35.37% of users gave Hims & Hers Health an outperform vote.

Hims & Hers HealthOutperform Votes
Underperform Votes
Teladoc HealthOutperform Votes
Underperform Votes

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 1.0% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Hims & Hers Health currently has a consensus price target of $16.43, suggesting a potential downside of 25.83%. Teladoc Health has a consensus price target of $18.22, suggesting a potential upside of 87.63%. Given Hims & Hers Health's higher possible upside, analysts clearly believe Teladoc Health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
0 Sell rating(s)
7 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
Teladoc Health
0 Sell rating(s)
12 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)


Hims & Hers Health beats Teladoc Health on 12 of the 18 factors compared between the two stocks.

Get Teladoc Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TDOC vs. The Competition

MetricTeladoc HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE Exchange
Market Cap$1.65B$855.44M$5.36B$17.71B
Dividend YieldN/AN/A2.85%3.62%
P/E Ratio-6.8932.83160.2324.44
Price / Sales0.631.512,165.6314.62
Price / Cash11.8973.6834.4719.18
Price / Book0.699.324.754.82
Net Income-$220.37M-$110.57M$110.97M$976.34M
7 Day Performance-2.90%-5.68%-2.22%0.93%
1 Month Performance-15.16%-3.54%-3.07%-1.78%
1 Year Performance-59.12%3.28%-2.76%9.91%

Teladoc Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
Hims & Hers Health
2.8684 of 5 stars
+165.6%$5.32B$872M-2,476.001,046Analyst Revision
0 of 5 stars
2.7749 of 5 stars
+90.7%$327.08M$152.55M-10.63207Positive News
AirSculpt Technologies
2.7269 of 5 stars
-48.7%$230.86M$195.92M200.50346Positive News
SHL Telemedicine
0.564 of 5 stars
-54.9%$77.66M$57.08M0.00583News Coverage
Pono Capital Two
0 of 5 stars
N/AN/A$71.15MN/A0.00N/APositive News
Oncology Institute
1.9183 of 5 stars
-18.3%$30.31M$324.24M-0.50800Gap Up
Cano Health
0 of 5 stars
N/AN/A$1.24M$3.14B0.002,700Gap Up
Concord Medical Services
0 of 5 stars
N/A-58.8%$0.00$75.69M0.00727Gap Down
4.666 of 5 stars
-47.5%$6.81B$1.06B74.164,200Positive News

Related Companies and Tools

This page (NYSE:TDOC) was last updated on 6/23/2024 by Staff

From Our Partners